Zobrazeno 1 - 10
of 132
pro vyhledávání: '"Giuseppe Vittorio De Socio"'
Autor:
Anna Gidari, Sara Benedetti, Sara Tordi, Anastasia Zoffoli, Debora Altobelli, Elisabetta Schiaroli, Giuseppe Vittorio De Socio, Daniela Francisci
Publikováno v:
Infectious Disease Reports, Vol 15, Iss 6, Pp 766-777 (2023)
Background: Bictegravir (BIC), a recently introduced integrase inhibitor, is available in a single tablet regimen with tenofovir alafenamide (TAF) and emtricitabine (FTC) (BIC-STR). This study aimed to describe a real-life experience with BIC-STR. Me
Externí odkaz:
https://doaj.org/article/85a7cb2e3aa845cc92ef9b7ba32f0f7d
Autor:
Marco Fois, Andrea De Vito, Francesca Cherchi, Elena Ricci, Michela Pontolillo, Katia Falasca, Nicolò Corti, Agnese Comelli, Alessandra Bandera, Chiara Molteni, Stefania Piconi, Francesca Colucci, Paolo Maggi, Vincenzo Boscia, Aakash Fugooah, Sara Benedetti, Giuseppe Vittorio De Socio, Paolo Bonfanti, Giordano Madeddu
Publikováno v:
Antibiotics, Vol 13, Iss 7, p 616 (2024)
Hospital-acquired pneumonia (HAP) and ventilation-associated pneumonia (VAP) are challenging clinical conditions due to the challenging tissue penetrability of the lung. This study aims to evaluate the potential role of fosfomycin (FOS) associated wi
Externí odkaz:
https://doaj.org/article/d9077f31ef63494f836ce2688d979d7a
Autor:
Luca Pipitò, Elena Delfina Ricci, Paolo Maggi, Giuseppe Vittorio De Socio, Giovanni Francesco Pellicano, Marcello Trizzino, Raffaella Rubino, Alessandra Lanzi, Lorenzo Crupi, Ilaria Capriglione, Nicola Squillace, Giuseppe Nunnari, Antonio Di Biagio, Paolo Bonfanti, Antonio Cascio
Publikováno v:
Viruses, Vol 16, Iss 5, p 777 (2024)
Background: The coexistence of HIV infection and latent tuberculosis infection (LTBI) presents a significant public health concern due to the increased risk of tuberculosis (TB) reactivation and progression to active disease. The multicenter observat
Externí odkaz:
https://doaj.org/article/f770217949174ba5b38105490e387dbd
Autor:
Nicolò Corti, Barbara Menzaghi, Giancarlo Orofino, Marta Guastavigna, Filippo Lagi, Antonio Di Biagio, Lucia Taramasso, Giuseppe Vittorio De Socio, Chiara Molteni, Giordano Madeddu, Elena Salomoni, Giovanni Francesco Pellicanò, Emanuele Pontali, Rita Bellagamba, Benedetto Maurizio Celesia, Antonio Cascio, Eleonora Sarchi, Roberto Gulminetti, Leonardo Calza, Paolo Maggi, Giovanni Cenderello, Alessandra Bandera, Maria Aurora Carleo, Katia Falasca, Sergio Ferrara, Salvatore Martini, Giuliana Guadagnino, Goffredo Angioni, Olivia Bargiacchi, Elena Delfina Ricci, Nicola Squillace, Paolo Bonfanti
Publikováno v:
Viruses, Vol 16, Iss 4, p 613 (2024)
Cardiovascular disease (CVD) is common in people with HIV (PWH), and has great impact in terms of morbidity and mortality. Several intertwined mechanisms are believed to play a role in determining the increased risk of CVD, including the effect of ce
Externí odkaz:
https://doaj.org/article/e23ab8dad6d14d519bbf95608db81b60
Autor:
Paolo Maggi, Elena Delfina Ricci, Stefania Cicalini, Giovanni Francesco Pellicanò, Benedetto Maurizio Celesia, Francesca Vichi, Antonio Cascio, Eleonora Sarchi, Giancarlo Orofino, Nicola Squillace, Giordano Madeddu, Giuseppe Vittorio De Socio, Olivia Bargiacchi, Chiara Molteni, Addolorata Masiello, Annalisa Saracino, Barbara Menzaghi, Katia Falasca, Lucia Taramasso, Antonio Di Biagio, Paolo Bonfanti
Publikováno v:
BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-6 (2023)
Abstract Background Doravirine (DOR) is a newly approved antiretroviral belonging to the class of non-nucleoside reverse transcriptase inhibitors (NNRTI), well tolerated and leading to an improved lipid profile in antiretroviral experienced people li
Externí odkaz:
https://doaj.org/article/6ef936eddd40410090a399bdd347aaf1
Autor:
Agnese Colpani, Andrea De Vito, Beatrice Zauli, Barbara Menzaghi, Andrea Calcagno, Benedetto Maurizio Celesia, Manuela Ceccarelli, Giuseppe Nunnari, Giuseppe Vittorio De Socio, Antonio Di Biagio, Nicola Leoni, Goffredo Angioni, Simona Di Giambenedetto, Gabriella D’Ettorre, Sergio Babudieri, Giordano Madeddu
Publikováno v:
Healthcare, Vol 12, Iss 4, p 417 (2024)
Poor knowledge of sexually transmitted infections (STIs) and HIV among people with HIV (PLHIV) could worsen life quality. We aimed to investigate their STI and HIV knowledge, disclosure and undetectable = untransmittable (U=U). We proposed an anonymo
Externí odkaz:
https://doaj.org/article/7915848643b3483981157c6136c9596c
Autor:
Giuseppe Vittorio De Socio, Sara Tordi, Debora Altobelli, Anna Gidari, Anastasia Zoffoli, Daniela Francisci
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 24, p 7759 (2023)
Background: The aim of the study is to evaluate the effectiveness, safety, and tolerability of a two-drug regimen (2-DR) dolutegravir/lamivudine (DTG/3TC) versus a three-drug regimen (3-DR) tenofovir alafenamide/emtricitabine/bictegravir (TAF/FTC/BIC
Externí odkaz:
https://doaj.org/article/22bd0869c57d4332aea28dc40cf627cf
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 13 (2023)
Clinical diagnostic laboratories produce one product—information—and for this to be valuable, the information must be clinically relevant, accurate, and timely. Although diagnostic information can clearly improve patient outcomes and decrease hea
Externí odkaz:
https://doaj.org/article/222c31f9151f47b2a95d7592d473d067
Autor:
Paolo Maggi, Giuseppe Vittorio De Socio, Barbara Menzaghi, Chiara Molteni, Nicola Squillace, Lucia Taramasso, Marta Guastavigna, Giulia Gamboni, Giordano Madeddu, Francesca Vichi, Antonio Cascio, Eleonora Sarchi, Giovanni Pellicanò, Canio Vito Martinelli, Benedetto Maurizio Celesia, Laura Valsecchi, Roberto Gulminetti, Giovanni Cenderello, Andrea Parisini, Leonardo Calza, Katia Falasca, Giancarlo Orofino, Elena Ricci, Antonio Di Biagio, Paolo Bonfanti
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background In persons living with HIV (PLWH), the burden of non-communicable chronic diseases increased over time, because of aging associated with chronic inflammation, systemic immune activation, and long-term exposure to the combination a
Externí odkaz:
https://doaj.org/article/5258cc1da7594012a6f8c2e34bbfab69
Autor:
Paolo Maggi, Elena Delfina Ricci, Canio Vito Martinelli, Giuseppe Vittorio De Socio, Nicola Squillace, Chiara Molteni, Addolorata Masiello, Giancarlo Orofino, Barbara Menzaghi, Rita Bellagamba, Francesca Vichi, Benedetto Maurizio Celesia, Giordano Madeddu, Giovanni Francesco Pellicanò, Maria Aurora Carleo, Antonio Cascio, Andrea Parisini, Lucia Taramasso, Laura Valsecchi, Leonardo Calza, Stefano Rusconi, Eleonora Sarchi, Salvatore Martini, Olivia Bargiacchi, Katia Falasca, Giovanni Cenderello, Sergio Ferrara, Antonio Di Biagio, Paolo Bonfanti
Publikováno v:
Viruses, Vol 15, Iss 7, p 1612 (2023)
Doravirine (DOR) is a newly approved non-nucleoside reverse transcriptase inhibitor (NNRTI). We aimed to investigate, in a real-life setting, how switching to a DOR-based regimen rather than a rilpivirine (RPV)-based regimen impacted metabolic and he
Externí odkaz:
https://doaj.org/article/888114b5ab2549fe87fea6592f2bd5e9